A randomized clinical trial of delirium treatment

A randomized clinical trial of delirium treatment - A randomized clinical trial of delirium treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010706

Enrollment

108

Registered

2013-06-30

Start date

2013-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delirium

Interventions

quetiapine perospirone risperidone

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients devoloping delirium during admission due to somatic diseases Delirium diagnosed according to DSM-IV-TR The score of DRS-R98: >14.5

Exclusion criteria

Exclusion criteria: 1) diabetes mellitis 2) severe liver dysfunction 3) under medication with antipsychotics 4) under medication with opioid 5) alcohol withdrawal

Design outcomes

Primary

Measure	Time frame
Time to first resolution of delirium	—

Secondary

Measure	Time frame
response rate discontinuation rate due to side effects	—

Countries

Japan

Contacts

Public ContactKotaro Hatta

Juntendo University Nerima Hospital Department of Psychiatry

khatta@juntendo.ac.jp03-5923-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026